Oxagen Ltd.

ACTIVE

United Kingdomwww.oxagen.co.ukHolding11–50 employeesEstablished: 1997-01-01

Clinical Trials

5 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1997

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

50.0%

Phase 1

25.0%

Trial Status Distribution

Active, not recruiting

41.7%

Completed

58.3%

Clinical Trials

Trials sponsored by this organization (12)

Proof of Concept Study of OC000459 in Eosinophilic Esophagitis

Phase 2

Completed

interventional

Aug 201026 participants

Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4

Phase 1

Completed

interventional

Feb 201020 participants

OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma

Phase 2

Completed

interventional

Apr 2009480 participants

Dose Finding Study in Patients with Mild to Moderate Persistent Asthma: A Parallel Group, Randomised, Placebo Controlled, Double Blind Assessment of Oral OC000459 Dosed at Three Dose Schedules for Twelve Weeks

Active, not recruiting

Mar 2009900 participants

Dose Finding Study in Patients with Mild to Moderate Persistent Asthma: A Parallel Group, Randomised, Placebo Controlled, Double Blind Assessment of Oral OC000459 Dosed at Three Dose Schedules for Twelve Weeks

Active, not recruiting

Jan 2009900 participants

OC000459 Dose Finding Study in Hay Fever Sufferers.

Phase 2

Completed

interventional

May 2008120 participants

A dose-finding study of the effects of OC000459 on responses to allergen challenge in the Vienna chamber in subjects known to suffer from grass pollen induced allergic rhinitis: a randomised, double-blind placebo-controlled, parallel group evaluation of the dose response curve and minimum effective dose given orally for eight days

Phase 1

Active, not recruiting

Apr 2008

A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis

Phase 2

Completed

interventional

Mar 200736 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations